1. HBW Insight
  2. >>Geography
  3. >>North America
  4. >>United States

Kratom Suspected In 35-State Salmonella Outbreak: Health And Wellness Industry News

Kratom suspected in 35-state salmonella outbreak; FTC mails refunds for false weight loss ads; Spear at tip of Nutrition 21 sales; and BioCell Collagen halal certified.

An outbreak of salmonella infections that FDA suspects is linked to products containing kratom has spread to 35 states and 40 of 55 infected people who were asked about the botanical reported consuming it before getting sick. According to FDA's March 15 update to its ongoing monitoring of the salmonella outbreak potentially linked to kratom, the investigation by the agency, Centers for Disease Control and Prevention and state and local officials includes four outbreak strains. Salmonella Javiana, Okatie and Thompson were identified after the outbreak was detected and linked to a single strain, salmonella I 4,[5],12:b:-, FDA says.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 
• By Eileen Francis

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

Adcomm Reform: Getting Needed Information More Important Than Vote Or Discussion

 
• By Derrick Gingery

US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

 
• By Malcolm Spicer

Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.